Seagen Inc.
Dosage and administration of non-fucosylated anti-CD40 antibodies

Last updated:

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.

Status:
Grant
Type:

Utility

Filling date:

29 Oct 2015

Issue date:

4 Jan 2022